I agree that this site is using cookies. You can find further informations here.
X
Karadkhele, Geeta
30  results:
Search for persons X
?
1

Belatacept with time-limited tacrolimus coimmunosuppression..:

Johnson, Aileen C. ; Zhang, Joan ; Karadkhele, Geeta...
American Journal of Transplantation.  24 (2024)  2 - p. 260-270 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The Burden and Impact of Early Post-transplant Multidrug-Re..:

Babiker, Ahmed ; Karadkhele, Geeta ; Bombin, Andrei...
Open Forum Infectious Diseases.  11 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

Belatacept‐based immunosuppression does not confer increase..:

Eichenberger, Emily M. ; Magua, Wairimu ; Rickert, Joseph B....
Transplant Infectious Disease.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Risk factors and outcomes of bloodstream infection from a u..:

Eichenberger, Emily M. ; Donzo, Maja Wichhart ; Anderson, Rebecca...
Clinical Transplantation.  38 (2024)  3 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
5

Impact of an ultrasensitive Cytomegalovirus quantitative nu..:

Beechar, Vivek B. ; Pouch, Stephanie M. ; Phadke, Varun K....
Transplant Infectious Disease.  26 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
6

2699. Risk of Bacterial Bloodstream Infection from a Urinar..:

Eichenberger, Emily ; Karadkhele, Geeta ; Johnson, Aileen C..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

Longitudinal Evaluation of Cytopenias in the Renal Transpla..:

Johnson, Aileen C. ; Karadkhele, Geeta ; Magua, Wairimu..
Transplantation Direct.  8 (2022)  6 - p. e1339 , 2022
Link: https://doi.org/10.1097/..
 
?
8

81. Impact of Early Post-Transplant Multidrug-Resistant Org..:

Babiker, Ahmed ; Karadkhele, Geeta ; Robichaux, Chad...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
9

Belatacept Conversion in Kidney After Liver Transplantation:

Cristea, Octav ; Karadkhele, Geeta ; Kitchens, William H....
Transplantation Direct.  7 (2021)  11 - p. e780 , 2021
Link: https://doi.org/10.1097/..
 
?
10

Temporal trends and current use of de novo belatacept in ki..:

Karadkhele, Geeta ; Duneton, Charlotte ; Garro, Rouba...
Clinical Transplantation.  36 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
11

CMV high-risk status and posttransplant outcomes in kidney ..:

Karadkhele, Geeta ; Hogan, Julien ; Magua, Wairimu...
American Journal of Transplantation.  21 (2021)  1 - p. 208-221 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Every 2-month belatacept maintenance therapy in kidney tran..:

Badell, Idelberto R. ; Parsons, Ronald F. ; Karadkhele, Geeta...
American Journal of Transplantation.  21 (2021)  9 - p. 3066-3076 , 2021
Link: https://doi.org/10.1111/..
 
?
13

CMV Status Drives Distinct Trajectories of CD4+ T Cell Diff..:

Zhang, Weiwen ; Morris, Anna B. ; Peek, Erica V....
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
14

Post-transplant lymphoproliferative disorder risk and outco..:

Koff, Jean L. ; Karadkhele, Geeta M. ; Switchenko, Jeffrey M....
Frontiers in Transplantation.  2 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
15

Three-year Outcomes After Conversion From Monthly to Every ..:

Johnson, Aileen C. ; Karadkhele, Geeta M. ; Shenvi, Neeta...
Transplantation Direct.  9 (2023)  3 - p. e1449 , 2023
Link: https://doi.org/10.1097/..
 
1-15